Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'

August 2020 in “ Journal of The American Academy of Dermatology ”

Domen Bukovac, Urška Makše

androgenetic alopecia AGA COVID-19 SARS-CoV-2 hair loss androgenic alopecia male pattern baldness

TLDR Hair loss link to COVID-19 severity likely due to other factors.

This document is a letter commenting on a study that found a correlation between androgenetic alopecia (AGA) and COVID-19 severity. The authors of the letter found inaccuracies in the analysis of the study and analyzed the raw data to match AGA prevalence in the age-matched population. They found that a higher prevalence of AGA in COVID-19 patients is most likely the consequence of other factors, causing older men to be more susceptible to SARS-CoV-2 infection.

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

119 citations, May 2020 in “Journal of The American Academy of Dermatology”

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations, August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

155 citations, December 2003 in “British Journal of Dermatology”

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Related Community Posts Join

6 / 1000+ results

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 864 upvotes 4 months ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA

in Research/Science 60 upvotes 4 years ago

The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.

community I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.

in Research/Science 150 upvotes 2 months ago

GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.

community I bought a microscope, how does my scalp/hairs look? I've been suffering diffuse thinning and hair loss after covid and never recovered (2 yrs ago) I eat healthy, in shape and workout.

in Progress Pictures 85 upvotes 11 months ago

A person with hair loss since COVID-19 is considering treatments like finasteride and minoxidil but is hesitant due to potential side effects. Suggestions include visiting a dermatologist, using a ketoconazole shampoo, and considering that post-COVID hair loss might be an autoimmune response.

community Being Safe on Oral Minoxidil: tl;dr on the literature.

in Research/Science 49 upvotes 1 month ago

Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

community Rosemary oil's potency as a dht blocker

in Research/Science 65 upvotes 1 year ago

Rosemary extract showed high inhibitory activity against DHT, similar to finasteride and dutasteride, but the conversation includes skepticism about its effectiveness in humans since the study was done on mice and rosemary oil is often considered ineffective based on personal experiences. Some suggest trying rosemary oil alongside other treatments, while others emphasize the difference between the extract used in the study and the oil.

Similar Research

6 / 1000+ results

research Dermatologic Manifestations of COVID-19: A Comprehensive Systematic Review

27 citations, November 2020 in “International Journal of Dermatology”

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management

7 citations, May 2022 in “The Journal of Dermatology”

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

research Androgenetic Alopecia and COVID-19: A Review of the Hypothetical Role of Androgens

9 citations, May 2021 in “Dermatologic Therapy”

Possible link between androgens and COVID-19 severity; more research needed.

research The Probable Destructive Mechanisms Behind COVID-19 on Male Reproductive System and Fertility

17 citations, May 2021 in “Journal of Assisted Reproduction and Genetics”

COVID-19 may harm male fertility and damage the reproductive system.

research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19

July 2023 in “Regenerative Therapy”

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster

research Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster

9 citations, November 2020 in “Medical Hypotheses”

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.